| Autor: |
Jarosław Szwalski, Michał Spych, Wiesław Tyliński, Jerzy Korczyński, Grzegorz Surkont, Małgorzata Moszyńska-Zielińska, Leszek Gottwald |
| Jazyk: |
angličtina |
| Rok vydání: |
2011 |
| Předmět: |
|
| Zdroj: |
Menopause Review, Vol 15, Iss 5, Pp 372-377 (2011) |
| Druh dokumentu: |
article |
| ISSN: |
1643-8876 |
| Popis: |
Introduction: Since 2009 the new FIGO Staging System of endometrial cancer, which changed the previousFIGO 1988 Staging System, has been present. Unfortunately, parallel use of both classifications is observed.Aim of study: to assess whether parallel use of the 2009 and the 1988 FIGO staging systems can causesignificant therapeutic mistakes in patients with endometrioid endometrial cancer.Material and methods: We analysed 262 patients with endometrioid endometrial cancer. The endometrialcancers were staged in both classifications. We analysed possible therapeutic mistakes caused by diverse nomenclature.Results: The patients at low risk, intermediate risk, and high risk for relapse were presented in: 110 (41.6%),109 (42.0%) and 43 (16.4%) cases, respectively. The possibility of inappropriate qualification for adjuvant treatmentoccurred in 102 patients (38.9%) if they were staged in the FIGO 1988 classification and interpreted as theFIGO 2009 classification, and similarly, in 65 patients (24.8%) if they were staged in the FIGO 2009 classificationand interpreted as the FIGO 1988 classification. The risk of a decision mistake in terms of the adjuvant treatmentdue to diverse nomenclature was observed commonly in 167 patients (63.7%).Conclusions: The common use of both FIGO staging systems for endometrioid endometrial cancer cancause significant therapeutic mistakes in terms of the adjuvant treatment. There is a need to use only the newFIGO 2009 Staging System for endometrial cancer and stop using the FIGO 1988 Staging System to avoid therapeuticmistakes. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
